RSAD2 and cancer: The interferon response gene RSAD2, upregulated mechanistically by the JAK/STAT interferon response and PI3K/AKT/mTOR pathways, is a key factor for metabolic reprogramming to enhance lipogenesis and glycolysis, thereby promoting stem-like properties of cancer stem cells and tumor proliferation [6].